Regarding possible liquid biomarkers, CSF sIL-2R and IL-10 levels have been suggested to differentiate CNS lymphoma from CNS inflammatory diseases (higher levels in lymphoma) (119). The gene discussed is IL10; the disease is primary central nervous system lymphoma.